Pfizer Inc. ( PFE) - Stock Earnings
PFE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
PFE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.6 billion USD | 17.6 billion USD |
| 2026Q1 | 2.7 billion USD | 14.5 billion USD |
| 2026Q2 | -246.0 million USD | 15.0 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
PFE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 2.1 billion USD | 59.6 billion USD |
| 2024 | 8.0 billion USD | 63.6 billion USD |
| 2025 | 7.8 billion USD | 62.6 billion USD |
| 2026 Est. | — | — |
PFE
List: Contenders
Price: $27.80
Dividend Yield: 6.05%
Forward Dividend Yield: 6.19%
Payout Ratio: -365.22%
Dividend Per Share: 1.72 USD
Earnings Per Share: 0.76 USD
P/E Ratio: 35.21
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 23.8 million
Ebitda: 3.6 billionMarket Capitalization: 162.1 billion
Average Dividend Frequency: 4
Years Paying Dividends: 55
DGR3: 2.45%
DGR5: -1.34%
DGR10: 8.70%
DGR20: 6.30%